Published mark
Longeveron Inc.
NASDAQ: LGVN. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:63265fda-219f-4a6b-b8dd-1c6707e73656
- SEC CIK
- 0001721484
- Record version
- vpublic-1:ro-d751713988987e9331980363e24189ce, published Oct 28, 2026
- Newest evidence
- Mar 17, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Stephen H. WillardSince Mar 17, 2026
- Chair
- Not published
- Independent
- 5 / 88 directors published
- Published claims
- 303 distinct sources
- Evidence records
- 90 pinned
- Source conflicts
- 0None open
Built from 3 distinct sources and 9 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
EXECUTIVE APPOINTED
Devin Blass executive of Longeveron Inc., effective 2026-03-17.
EffectiveEffective Mar 17, 2026E3
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Chief Technology Officer and Senior Vice President of Chemistry, Manufacturing, and Controls | Devin Blass | Mar 2026 | current | Source reportedE3 |
| Co-Founder, Chief Science Officer, Executive Chairman and Director | Joshua M. Hare, M.D. | Mar 2026 | current | Source reportedE4 |
| Chief Financial Officer and Treasurer | Lisa A. Locklear | Mar 2026 | current | Source reportedE5 |
| Chief Medical Officer | Nataliya Agafonova, M.D. | Mar 2026 | current | Source reportedE6 |
| General Counsel and Secretary | Paul Lehr, J.D. | Mar 2026 | current | Source reportedE7 |
| Chief Executive Officer | Stephen H. Willard | Mar 2026 | current | Source reportedE8 |
Board of directors
Evidence8 directors published. 5 of 8 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Joshua M. Hare | Not independent | 2014 | None published | Source reportedE2 |
| Khoso Baluch | Independent | 2023 | Audit, chairAudit · Chair; CompensationCompensation | Source reportedE2 |
| Neha Motwani | Independent | 2024 | AuditAudit; Nominating and GovernanceNominating and Governance | Source reportedE2 |
| Richard Kender | Independent | 2024 | AuditAudit; CompensationCompensation | Source reportedE2 |
| Rock Soffer | Not independent | 2020 | None published | Source reportedE2 |
| Roger Hajjar | Independent | 2024 | Nominating and Governance, chairNominating and Governance · Chair | Source reportedE2 |
| Ursula Ungaro | Independent | 2021 | Compensation, chairCompensation · Chair; Nominating and GovernanceNominating and Governance | Source reportedE2 |
| Wael Hashad | Not independent | 2023 | None published | Source reportedE2 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Khoso Baluch | Khoso Baluch, Neha Motwani, Richard Kender | Not described in the published record |
| Audit · Chair; Compensation | Not published | Khoso Baluch | Not described in the published record |
| Audit; Compensation | Not published | Richard Kender | Not described in the published record |
| Audit; Nominating and Governance | Not published | Neha Motwani | Not described in the published record |
| Compensation | Ursula Ungaro | Ursula Ungaro, Khoso Baluch, Richard Kender | Not described in the published record |
| Compensation · Chair; Nominating and Governance | Not published | Ursula Ungaro | Not described in the published record |
| Nominating and Governance | Roger Hajjar | Roger Hajjar, Neha Motwani, Ursula Ungaro | Not described in the published record |
| Nominating and Governance · Chair | Not published | Roger Hajjar | Not described in the published record |
Committee RecordAudit: Chair Khoso Baluch; Members Khoso Baluch (Chair); Neha Motwani; Richard Kender
Committee AppointmentKhoso Baluch: chair, Audit
Committee AppointmentNeha Motwani: member, Audit
Committee AppointmentRichard Kender: member, Audit
Committee RecordCompensation: Chair Ursula Ungaro; Members Ursula Ungaro (Chair); Khoso Baluch; Richard Kender
Committee AppointmentUrsula Ungaro: chair, Compensation
Committee AppointmentKhoso Baluch: member, Compensation
Committee AppointmentRichard Kender: member, Compensation
Committee RecordNominating and Governance: Chair Roger Hajjar; Members Roger Hajjar (Chair); Neha Motwani; Ursula Ungaro
Committee AppointmentRoger Hajjar: chair, Nominating and Governance
Committee AppointmentNeha Motwani: member, Nominating and Governance
Committee AppointmentUrsula Ungaro: member, Nominating and Governance
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerStephen H. Willard, Chief Executive Officer, from Mar 17, 2026
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceSecurity ListingLGVN (NASDAQ)
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 28, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameLongeveron Inc.
Entity StatusPublic listing published
Published FactUS
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Devin BlassChief Technology Officer and Senior Vice President of Chemistry, Manufacturing, and Controlscompany:63265fda-219f-4a6b-b8dd-1c6707e73656:leadership_role:13
- Joshua M. Hare, M.D.Co-Founder, Chief Science Officer, Executive Chairman and Directorcompany:63265fda-219f-4a6b-b8dd-1c6707e73656:leadership_role:14
- Lisa A. LocklearChief Financial Officer and Treasurercompany:63265fda-219f-4a6b-b8dd-1c6707e73656:leadership_role:15
- Nataliya Agafonova, M.D.Chief Medical Officercompany:63265fda-219f-4a6b-b8dd-1c6707e73656:leadership_role:16
- Paul Lehr, J.D.General Counsel and Secretarycompany:63265fda-219f-4a6b-b8dd-1c6707e73656:leadership_role:17
- Stephen H. WillardChief Executive Officercompany:63265fda-219f-4a6b-b8dd-1c6707e73656:leadership_role:18
- Joshua M. HareDirectorcompany:63265fda-219f-4a6b-b8dd-1c6707e73656:leadership_role:5
- Khoso BaluchDirectorcompany:63265fda-219f-4a6b-b8dd-1c6707e73656:leadership_role:6
- Neha MotwaniDirectorcompany:63265fda-219f-4a6b-b8dd-1c6707e73656:leadership_role:7
- Richard KenderDirectorcompany:63265fda-219f-4a6b-b8dd-1c6707e73656:leadership_role:8
- Rock SofferDirectorcompany:63265fda-219f-4a6b-b8dd-1c6707e73656:leadership_role:9
- Roger HajjarDirectorcompany:63265fda-219f-4a6b-b8dd-1c6707e73656:leadership_role:10
- Ursula UngaroDirectorcompany:63265fda-219f-4a6b-b8dd-1c6707e73656:leadership_role:11
- Wael HashadDirectorcompany:63265fda-219f-4a6b-b8dd-1c6707e73656:leadership_role:12
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 9 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 28, 2026. Cited by 4 Claims.
- E2sec proxy. Published Apr 28, 2025. Retrieved Apr 28, 2026. Cited by 8 Claims.
- E3sec filing. Published Mar 17, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E4sec filing. Published Mar 17, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E5sec filing. Published Mar 17, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E6sec filing. Published Mar 17, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E7sec filing. Published Mar 17, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E8sec filing. Published Mar 17, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E9board_seats. board seats. Cited by 12 Claims.
What changed in version public-1:ro-d751713988987e9331980363e24189ce
vpublic-1:ro-d751713988987e9331980363e24189ce published Oct 28, 2026- Devin Blass executive of Longeveron Inc., effective 2026-03-17.
- Joshua M. Hare, M.D. executive of Longeveron Inc., effective 2026-03-17.
- Lisa A. Locklear executive of Longeveron Inc., effective 2026-03-17.
- Nataliya Agafonova, M.D. executive of Longeveron Inc., effective 2026-03-17.
- Paul Lehr, J.D. executive of Longeveron Inc., effective 2026-03-17.
- Stephen H. Willard executive of Longeveron Inc., effective 2026-03-17.
- Neha Motwani seat on Longeveron Inc., effective 2024-01-01.
- Richard Kender seat on Longeveron Inc., effective 2024-01-01.
- Roger Hajjar seat on Longeveron Inc., effective 2024-01-01.
- Audit; Compensation committee of Longeveron Inc., effective 2024-01-01.
- Richard Kender member of Audit; Compensation, effective 2024-01-01.
- Audit; Nominating and Governance committee of Longeveron Inc., effective 2024-01-01.
- Neha Motwani member of Audit; Nominating and Governance, effective 2024-01-01.
- Nominating and Governance · Chair committee of Longeveron Inc., effective 2024-01-01.
- Roger Hajjar member of Nominating and Governance · Chair, effective 2024-01-01.
- Khoso Baluch seat on Longeveron Inc., effective 2023-01-01.
- Wael Hashad seat on Longeveron Inc., effective 2023-01-01.
- Audit · Chair; Compensation committee of Longeveron Inc., effective 2023-01-01.
- Khoso Baluch member of Audit · Chair; Compensation, effective 2023-01-01.
- Ursula Ungaro seat on Longeveron Inc., effective 2021-01-01.
- Compensation · Chair; Nominating and Governance committee of Longeveron Inc., effective 2021-01-01.
- Ursula Ungaro member of Compensation · Chair; Nominating and Governance, effective 2021-01-01.
- Rock Soffer seat on Longeveron Inc., effective 2020-01-01.
- Joshua M. Hare seat on Longeveron Inc., effective 2014-01-01.